2.25
-0.23(-9.27%)
Currency In USD
Address
2401 S. Foothill Dr.
Salt Lake City, UT 84109
United States of America
Phone
801 438 1036
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
132
First IPO Date
July 12, 2017
| Name | Title | Pay | Year Born |
| Dwight H. Egan | Chairman & Chief Executive Officer | 411,667 | 1953 |
| Brian L. Brown | Chief Financial Officer & Company Secretary | 328,333 | 1976 |
| Richard David Abbott | President | 346,999 | 1972 |
| Mayuranki Almaula | Senior Vice President of Overseas Operations & Strategic Alliances | 0 | N/A |
| Andrew Benson | Head of Investor Relations | 0 | N/A |
| Christopher Thurston | Chief Technology Officer | 0 | N/A |
| Dan Bohrer | Vice President of Finance & Accounting | 0 | N/A |
| David Nielsen | Chief Operating Officer | 0 | N/A |
| Seth Egan | Chief Commercialization Officer | 0 | N/A |
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.